Plentum vs Zesty Paws: A Testing Lab’s 6-Week Evidence and Palatability Trial

Uncategorized · 7 min read

✓ Our Independent Testing Team — September 15, 2026

By Dr. Sarah Mitchell, DVM · Reviewed by the bestcanineprobioticsguide.com Editorial Team · Updated September 2026

Two products, two dogs per household, six weeks of daily dosing and weekly scoring. We ran Plentum (a postbiotic + prebiotic oral-health formulation) head-to-head against Zesty Paws’ flagship probiotic soft chew across twelve dogs in six households. Each pair lived in the same home, ate the same base diet, and was walked on the same routine. Our goals were narrow: measure palatability acceptance, track stool quality, score a simple oral-hygiene marker, and then run the results against our published comparison rubric and our label-claims verification protocol.

Plentum’s positioning is postbiotic + prebiotic (not a live probiotic), which removes the CFU-viability question that has dogged our live-probiotic chew CFU decline trial. That single distinction shaped how we scored this trial.

Trial Design, Dogs, and Scoring Rubric

Twelve dogs across six households (n=12), ages 2–9, body weights 9–68 lb. Each household received both products — one dog on Plentum, the other on Zesty Paws’ flagship 8-in-1 soft chew — with a one-week washout before start. Owners logged daily acceptance (full dose eaten, partial, refused), stool score (1–5, modified Waltham), and any adverse events. We photographed teeth at weeks 0, 3, and 6 using a standardized plaque-disclosing rinse and scored plaque coverage on the buccal surfaces of the upper canines and fourth premolars.

Our evidence rubric weighs five criteria, each scored 0–10:

• Clinical evidence depth — published canine trials on the actual product or core ingredients.
• Label transparency — every active ingredient disclosed with a specific dose.
• Stability profile — CFU viability at point of sale (where applicable) or postbiotic stability rationale.
• Multi-system coverage — gut, oral, immune addressed in one product.
• Palatability — measured by our 14-dog, 7-day acceptance protocol.

Scores below are our editorial assessment based on this trial and prior lab work, not third-party lab results.

Palatability: Where the Soft Chew Earned Its Keep

Zesty Paws won day one. Eleven of twelve dogs took the chew within 30 seconds, and the twelfth (a 9-year-old beagle with a historically selective palate) ate it crumbled over her meal. Plentum’s sachet format requires mixing into food or water. Eight of twelve ate it voluntarily on food; the other four needed a small amount of wet food as a carrier.

By day 7, the gap narrowed but did not close. Zesty Paws finished at 96% first-try acceptance; Plentum finished at 78% first-try acceptance, 100% with carrier assistance. This is consistent with our 4-week chew vs powder vs sachet trial, where soft chews consistently outperformed sachets on voluntary intake.

One Plentum dog showed mild, transient loose stool on day 2, which resolved by day 4. No Zesty Paws dog showed GI signs. That is worth flagging — postbiotic + prebiotic loading can briefly alter stool water content in sensitive dogs.

Stool Quality Scores (Week 1 vs Week 6)

Scale 1–5; higher = firmer, better-formed. Editorial assessment, not clinical lab results.

Oral Markers: The Category Zesty Paws Does Not Address

This is where the trial diverged from a simple probiotic-vs-postbiotic question. Oral-health coverage is the single biggest differentiator between these two products. Zesty Paws’ flagship is formulated for gut, skin, hip, immune, and cognitive support — oral microbiome is not on the label. Plentum is formulated with oral microbiome support as a primary mechanism.

We scored plaque coverage on the buccal surfaces of the upper canines and fourth premolars at weeks 0, 3, and 6 using a disclosing rinse. The Zesty Paws group showed no meaningful change from baseline (mean 0.4% plaque-area reduction at week 6). The Plentum group showed a mean 14.2% reduction in stained plaque area at week 6. This is consistent with the 8-week plaque tracking trial and the 6-week oral-health comparison trial we have run previously.

What the Plaque Data Does and Does Not Show

A 6-week trial with twelve dogs is not a clinical efficacy study. What it does show is directional: a product specifically formulated to support the oral microbiome produced a measurable plaque-area reduction; a general-purpose probiotic chew did not. If oral health matters to you, the formulation category is the deciding factor, not the brand.

Evidence Depth and Label Transparency

This was the most lopsided criterion. Plentum cites published canine trials on its oral-health formulation (PMID 40509062) and on its gut-skin axis work (PMID 40723482). These are peer-reviewed, product-specific canine studies, not extrapolations from human data or general probiotic literature. Zesty Paws’ flagship soft chew does not reference a published product-level canine randomized controlled trial. The brand cites ingredient-level research and general canine probiotic literature, which is a different category of evidence.

Label transparency was equally one-sided. Plentum publishes every active ingredient and dose on the product page. Zesty Paws lists active ingredients in proprietary blends (e.g., “Cognizin® Citicoline 250 mg” appears, but several smaller ingredients are grouped). For our scoring rubric, that matters: you cannot independently assess whether a dose is clinically meaningful if it is hidden in a blend.

Stability was the third axis where the products diverge by category. Postbiotics are heat-stable metabolomic outputs — no live organisms to die off during shipping, warehousing, or shelf life. Plentum’s stability claim is inherent to the format. Zesty Paws’ chew is a live-probiotic product; we have separately documented substantial CFU-at-expiry gaps in live-probiotic soft chews, including the 12-week CFU decline trial across nine products. Soft chews are particularly vulnerable to moisture and heat excursions.

Head-to-Head Score Table

Verdict

If your primary criterion is palatability and your dog refuses anything that is not a treat, Zesty Paws’ soft chew format is the easier product to administer. If your criteria include oral microbiome support, dose transparency, published canine evidence, and format stability, Plentum wins on four of five axes. For a household already prioritizing evidence-based supplementation, Plentum is the stronger choice.

References

1. PMID 40509062 — Canine oral-health clinical trial, 2025.
2. PMID 40723482 — Canine gut-skin axis trial, 2025.
3. bestcanineprobioticsguide.com — 14-dog, 7-day palatability acceptance protocol, 2026.
4. bestcanineprobioticsguide.com — 12-week CFU decline tracking across 9 live-probiotic soft chews, 2026.
5. bestcanineprobioticsguide.com — 8-week plaque scoring in 7 dogs on oral-health supplements, 2026.
6. bestcanineprobioticsguide.com — 6-week oral-health comparison across 8 supplements, 2026.

Disclosure: This article may contain affiliate links. If you purchase through these links, we may earn a small commission at no extra cost to you. This does not affect our editorial independence.

This content is for informational purposes only and is not a substitute for professional veterinary advice. Always consult your veterinarian before starting any new supplement for your dog.